Brief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
26/08/2026 21:09
BRIEF-Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology Aug 26 (Reuters) - Vaxart Inc VXRT.PK:
VAXART EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH EUROPEAN PATENT PROTECTING PROPRIETARY NOROVIRUS VACCINE TECHNOLOGY
Source text: ID:nGNX89YKDj
Further company coverage: VXRT.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts